Mallinckrodt Pharmaceuticals Supports Science Week Ireland Chemistry Workshop Roadshow for County Meath Students

DUBLIN, November 12, 2015 /PRNewswire/ --

Seeing chemistry in action is believing for more than 300 students at the Ashbourne Community School in County Meath as they learn how science, technology and engineering relate to everyday life when the Chemistry Workshop Roadshow visits their school on Friday morning, 13 November 2015.

Mallinckrodt Pharmaceuticals , a leading specialty biopharmaceutical company, is a proud supporter of bringing the roadshow to children and teachers. The workshop is part of more than 800 Science Week Ireland events taking place across the country from 8-15 November 2015. The Chemistry Workshop Roadshow at Ashbourne Community School run by Mad Science includes live and hands-on demonstrations of varied visible chemical reactions.

Having first taken place in 1996, Science Week Ireland aims to make science more interesting and accessible to children and adults alike. The week highlights how science, technology and engineering are hugely relevant as well as how they lead to interesting and exciting career options and help develop creativity among children.

These promising career options include those in the healthcare and pharmaceutical industries and Mallinckrodt's support of Science Week Ireland aligns with its global support of Science, Technology, Engineering and Math (STEM) initiatives, said Elizabeth Collins, Senior Director, Quality, for Global External Supply at Mallinckrodt Pharmaceuticals Ireland. Mallinckrodt has more than 120 employees based at its offices and existing manufacturing site in Dublin, and the company has invested more than €165 million in Ireland over the past two decades.

"These are exciting times for Ireland's pharmaceutical sector, which has seen more than €3 billion in recent capital investment as well as sustained growth," said Collins. "This event helps to show how chemistry is relevant in real-life activities that we do each day, and Science Week Ireland demonstrates how important the advancement of science, technology and engineering is for our economy and society and the promise that creating a diverse pipeline of science professionals can have for Ireland."

ABOUT MALLINCKRODT:

Mallinckrodt is a global specialty biopharmaceutical and imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Areas of focus include therapeutic drugs for autoimmune and rare disease specialty areas like neurology, rheumatology, nephrology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; and analgesics and central nervous system drugs. The company's core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. To learn more about Mallinckrodt, visit http://www.mallinckrodt.com.